Ciba Specialty and Novartis Pharma join InnoCentive's online scientific forum

July 2005
Chemical Business;Jul2005, Vol. 19 Issue 7, p60
Trade Publication
Reports on the decision of Ciba Specialty Chemicals and Novartis Pharma AG to join the online scientific forum of InnoCentive. Renewal of the contract of InnoCentive with Dow; Companies involved in research and development initiatives.


Related Articles

  • Ciba buys a Dow epoxy line. Walsh, Kerri // Chemical Week;10/8/1997, Vol. 159 Issue 38, p38 

    Presents the acquisition of Ciba Specialty Chemical company's Performance Polymers Division for Dow Chemical's multifunctional epoxy systems and cyanate esters resins product lines. Terms of the acquisition agreement; How Ciba will benefit from the acquisition.

  • New Products Come to Light at Radtech. Schmitt, Bill; Valero, Greg // Chemical Week;5/8/2002, Vol. 164 Issue 19, p32 

    Deals with the chemical products introduced at Radtech 2002 biannual conference for ultraviolet and electron beam radiation curing chemicals in Indianapolis, Indiana. Curing technique for epoxy introduced by Ciba Specialty Chemicals; Information on the adhesives and coatings monomer from Dow...

  • Strike back on pricing. Chang, Joseph // ICIS Chemical Business;6/9/2008, Vol. 273 Issue 23, p12 

    The article examines the impact of the increasing oil prices on the state of chemical industry in the U.S. in 2008. It is revealed that various chemical product manufacturers had decided to increase the prices of its own products due to their high expenses. They include Dow Chemical Co., Rohm &...

  • Takeover track record. NIELSEN, KAROL; ALPEROWICZ, NATASHA // Chemical Week;11/18/1998, Vol. 160 Issue 44, p29 

    Focuses on various chemical industry mergers that have closed since early 1996. Completion of the work of Dow Chemical company to integrate Sentrachem company in Johannesburg since its December 1997 acquisition; Evaluation of Crompton & Knowles' acquisition of Uniroyal Chemical company; Details...

  • Ciba beefs up specialty resin business.  // Chemical Market Reporter;10/06/97, Vol. 252 Issue 14, p3 

    Reports on Ciba Specialty Chemicals Corp.'s acquisition of the specialty resin businesses of Dow Chemical Co. and AlliedSignal Inc. Dow Chemical's sale of its Tactix epoxy resin and Quatrex synthetic resin lines; AlliedSignal's divestment of its Exactomer stereolithography resin unit; Focus of...

  • TOP STORIES FROM ICIS news.  // ICIS Chemical Business;2/12/2007, Vol. 2 Issue 53, p6 

    The article offers news briefs on the chemical industry. Due to land shortage, Formosa Petrochemical Corp. might delay the start-up of its largest cracker to the fourth quarter of 2007 and reduce its capacity. Dow Chemical remains committed to its delayed joint-venture petrochemicals project in...

  • MERGERS & ACQUISITIONS.  // Paint & Coatings Industry;Mar2007, Vol. 23 Issue 3, p24 

    The article reports on merger and acquisition deals in the paint and coatings industry in the U.S. International Paper has decided to sell its Arizona Chemical business to Rhone Capital III LP. An agreement has been reached by the Dow Chemical Co. and the Bayer Group for Dow to acquire Bayer's...

  • Ciba Focuses on Building New Product Sales. D'Amico, Esther // Chemical Week;11/10/2004, Vol. 166 Issue 37, p26 

    Reports on the focus of Ciba Specialty Chemicals on innovation and new products. Establishment of a research fund for special projects by the company; Difference between the research and development of the company's core business and advancement activities; Budget allotted by the company on...

  • Innovation at Work: Ciba Seeks to Raise the R&D Bar. van Arnum, Patricia // Chemical Market Reporter;12/20/2004, Vol. 266 Issue 20, p17 

    The article reports that Ciba Specialty Chemicals Corp. is proceeding with a strategy to raise its level of new product and service development by using an end-market approach to innovation. Its innovation strategy is focused on technology sharing across the organization, shifting research and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics